Tag: managed entry schemes

Implementation of “Coverage With Evidence Development” Drug Approval Strategies Found Lacking

Value in Health announced the publication of new research from The Netherlands showing important gaps in the deployment of “coverage with evidence development,” a type of pharmaceutical managed entry agreement that gives patients access to treatments while additional evidence is being collected.

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

The Changing Landscape for Medical Devices

Examining the Impact of New European Regulations and Managed Entry Schemes on the Device Marketplace Glasgow, Scotland, UK—7 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held several sessions on the topic of medical devices at its

Posted in Announcements, ISPOR News & Press Tagged with: , ,